Skip to main content
Erschienen in: Abdominal Radiology 4/2013

01.08.2013 | Pictorial Essay

MDCT findings after hepatic chemoembolization with DC-beads: What the radiologist needs to know

verfasst von: Juan Carlos Spina, Marina Ulla, Ezequiel Levy Yeyati, Mariana Cecilia Kucharczyk, Hernan Irusta, Jesica Lorena Savluk, Ricardo García-Mónaco

Erschienen in: Abdominal Radiology | Ausgabe 4/2013

Einloggen, um Zugang zu erhalten

Abstract

Transcatheter arterial chemoembolization with drug-eluting beads (TACE-DC-beads) is a new local treatment for primary or metastatic liver tumors. Despite technical efforts to achieve highly selective embolization of the tumor-supplying vessels, small, or large insults to the non-tumorous parenchyma are inevitably induced by the embolic materials or procedure itself. Parenchymal changes following TACE-DC-beads include bile duct injuries (bile duct dilatation, periportal edema, and bilomas), obliteration of intrahepatic portal vein branches, hypodense ill-defined areas, and perilesional parenchymal enhancement. The radiologist must be familiar with the changes induced by this treatment in order to distinguish therapeutic effect and collateral findings from complications and residual or recurrent tumor.
Literatur
1.
Zurück zum Zitat Lewandowski RJ, Geschwind JF, Liapi E, et al. (2011) Transcatheter intraarterial therapies: rationale and overview. Radiology 259(3):641–657PubMedCrossRef Lewandowski RJ, Geschwind JF, Liapi E, et al. (2011) Transcatheter intraarterial therapies: rationale and overview. Radiology 259(3):641–657PubMedCrossRef
2.
Zurück zum Zitat de Baere T, Deschamps F (2011) Arterial therapies of colorectal cancer metastases to the liver. Abdom Imaging 36(6):661–670PubMedCrossRef de Baere T, Deschamps F (2011) Arterial therapies of colorectal cancer metastases to the liver. Abdom Imaging 36(6):661–670PubMedCrossRef
3.
Zurück zum Zitat Huppert P (2011) Current concepts in transarterial chemoembolization of hepatocellular carcinoma. Abdom Imaging 36(6):677–683PubMedCrossRef Huppert P (2011) Current concepts in transarterial chemoembolization of hepatocellular carcinoma. Abdom Imaging 36(6):677–683PubMedCrossRef
4.
Zurück zum Zitat Hoffmann RT, Paprottka P, Jakobs TF, et al. (2011) Arterial therapies of non-colorectal cancer metastases to the liver (from chemoembolization to radioembolization). Abdom Imaging 36(6):671–676PubMedCrossRef Hoffmann RT, Paprottka P, Jakobs TF, et al. (2011) Arterial therapies of non-colorectal cancer metastases to the liver (from chemoembolization to radioembolization). Abdom Imaging 36(6):671–676PubMedCrossRef
5.
Zurück zum Zitat Reyes DK, Vossen JA, Kamel IR, et al. (2009) Single-center phase II trial of transarterial chemoembolization with drug-eluting beads for patients with unresectable hepatocellular carcinoma: initial experience in the United States. Cancer J 15(6):526–532PubMedCrossRef Reyes DK, Vossen JA, Kamel IR, et al. (2009) Single-center phase II trial of transarterial chemoembolization with drug-eluting beads for patients with unresectable hepatocellular carcinoma: initial experience in the United States. Cancer J 15(6):526–532PubMedCrossRef
6.
Zurück zum Zitat Shin SW (2009) The current practice of transarterial chemoembolization for the treatment of hepatocellular carcinoma. Korean J Radiol 10(5):425–434PubMedCrossRef Shin SW (2009) The current practice of transarterial chemoembolization for the treatment of hepatocellular carcinoma. Korean J Radiol 10(5):425–434PubMedCrossRef
7.
Zurück zum Zitat Varela M, Real MI, Burrel M, et al. (2007) Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics. J Hepatol 46(3):474–481PubMedCrossRef Varela M, Real MI, Burrel M, et al. (2007) Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics. J Hepatol 46(3):474–481PubMedCrossRef
8.
Zurück zum Zitat Chung JW, Park JH, Han JK, et al. (1996) Hepatic tumors: predisposing factors for complications of transcatheter oily chemoembolization. Radiology 198(1):33–40PubMed Chung JW, Park JH, Han JK, et al. (1996) Hepatic tumors: predisposing factors for complications of transcatheter oily chemoembolization. Radiology 198(1):33–40PubMed
9.
Zurück zum Zitat Kim HK, Chung YH, Song BC, et al. (2001) Ischemic bile duct injury as a serious complication after transarterial chemoembolization in patients with hepatocellular carcinoma. J Clin Gastroenterol 32(5):423–427PubMedCrossRef Kim HK, Chung YH, Song BC, et al. (2001) Ischemic bile duct injury as a serious complication after transarterial chemoembolization in patients with hepatocellular carcinoma. J Clin Gastroenterol 32(5):423–427PubMedCrossRef
10.
Zurück zum Zitat Sakamoto I, Iwanaga S, Nagaoki K, et al. (2003) Intrahepatic biloma formation (bile duct necrosis) after transcatheter arterial chemoembolization. AJR Am J Roentgenol 181(1):79–87PubMedCrossRef Sakamoto I, Iwanaga S, Nagaoki K, et al. (2003) Intrahepatic biloma formation (bile duct necrosis) after transcatheter arterial chemoembolization. AJR Am J Roentgenol 181(1):79–87PubMedCrossRef
11.
Zurück zum Zitat Namur J, Wassef M, Millot JM, et al. (2010) Drug-eluting beads for liver embolization: concentration of doxorubicin in tissue and in beads in a pig model. J Vasc Interv Radiol 21(2):259–267PubMedCrossRef Namur J, Wassef M, Millot JM, et al. (2010) Drug-eluting beads for liver embolization: concentration of doxorubicin in tissue and in beads in a pig model. J Vasc Interv Radiol 21(2):259–267PubMedCrossRef
12.
Zurück zum Zitat Makuuchi MB, Sukigara M, Mori T, et al. (1985) Bile duct necrosis: complication of transcatheter hepatic arterial embolization. Radiology 156(2):331–334PubMed Makuuchi MB, Sukigara M, Mori T, et al. (1985) Bile duct necrosis: complication of transcatheter hepatic arterial embolization. Radiology 156(2):331–334PubMed
13.
Zurück zum Zitat Chung J, Yu JS, Chung JJ, et al. (2010) Haemodynamic events and localised parenchymal changes following transcatheter arterial chemoembolisation for hepatic malignancy: interpretation of imaging findings. Br J Radiol 83(985):71–81PubMedCrossRef Chung J, Yu JS, Chung JJ, et al. (2010) Haemodynamic events and localised parenchymal changes following transcatheter arterial chemoembolisation for hepatic malignancy: interpretation of imaging findings. Br J Radiol 83(985):71–81PubMedCrossRef
14.
Zurück zum Zitat Shigemura T, Yamamoto F, Shilpakar SK, et al. (1995) MRI differential diagnosis of intrahepatic biloma from subacute hematoma. Abdom Imaging 20(3):211–213PubMedCrossRef Shigemura T, Yamamoto F, Shilpakar SK, et al. (1995) MRI differential diagnosis of intrahepatic biloma from subacute hematoma. Abdom Imaging 20(3):211–213PubMedCrossRef
15.
Zurück zum Zitat Novick SL, Fishman EK (1998) Portal vein thrombosis: spectrum of helical CT and CT angiographic findings. Abdom Imaging 23(5):505–510PubMedCrossRef Novick SL, Fishman EK (1998) Portal vein thrombosis: spectrum of helical CT and CT angiographic findings. Abdom Imaging 23(5):505–510PubMedCrossRef
16.
Zurück zum Zitat Yu JS, Kim KW, Jeong MG, et al. (2002) Predisposing factors of bile duct injury after transcatheter arterial chemoembolization (TACE) for hepatic malignancy. Cardiovasc Intervent Radiol 25(4):270–274PubMedCrossRef Yu JS, Kim KW, Jeong MG, et al. (2002) Predisposing factors of bile duct injury after transcatheter arterial chemoembolization (TACE) for hepatic malignancy. Cardiovasc Intervent Radiol 25(4):270–274PubMedCrossRef
17.
Zurück zum Zitat Adler DD, Glazer GM, Silver TM (1984) Computed tomography of liver infarction. AJR Am J Roentgenol 142(2):315–318PubMedCrossRef Adler DD, Glazer GM, Silver TM (1984) Computed tomography of liver infarction. AJR Am J Roentgenol 142(2):315–318PubMedCrossRef
18.
Zurück zum Zitat Lim HK, Choi D, Lee WJ, et al. (2001) Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: evaluation with follow-up multiphase helical CT. Radiology 221(2):447–454PubMedCrossRef Lim HK, Choi D, Lee WJ, et al. (2001) Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: evaluation with follow-up multiphase helical CT. Radiology 221(2):447–454PubMedCrossRef
Metadaten
Titel
MDCT findings after hepatic chemoembolization with DC-beads: What the radiologist needs to know
verfasst von
Juan Carlos Spina
Marina Ulla
Ezequiel Levy Yeyati
Mariana Cecilia Kucharczyk
Hernan Irusta
Jesica Lorena Savluk
Ricardo García-Mónaco
Publikationsdatum
01.08.2013
Verlag
Springer US
Erschienen in
Abdominal Radiology / Ausgabe 4/2013
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-012-9963-6

Weitere Artikel der Ausgabe 4/2013

Abdominal Radiology 4/2013 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

S3-Leitlinie zu Pankreaskrebs aktualisiert

23.04.2024 Pankreaskarzinom Nachrichten

Die Empfehlungen zur Therapie des Pankreaskarzinoms wurden um zwei Off-Label-Anwendungen erweitert. Und auch im Bereich der Früherkennung gibt es Aktualisierungen.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

13.04.2024 Klinik aktuell Kongressbericht

Die Teilnehmer eines Forums beim DGIM-Kongress waren sich einig: Fehler in der Medizin sind häufig in ungeeigneten Prozessen und mangelnder Kommunikation begründet. Gespräche mit Patienten und im Team können helfen.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.